Atlas Trials

Impact of Alpha-Lipoic Acid Ingestion on Glucose Tolerance in Subjects With Pre-Diabetes

Clinical trial NCT03612037 · COMPLETED

Trial details

NCT number
NCT03612037
Sponsor
State University of New York at Buffalo
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
PreDiabetes
Start date
2016-09-01
Primary completion
2018-12-30
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.